What is Xeris Biopharma Holdings, Inc.'s net debt / EBITDA?

Xeris Biopharma Holdings, Inc. (XERS) reported net debt / EBITDA of 3.9× in Q1 2026.

What does net debt / EBITDA mean?

Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.

Xeris Biopharma Holdings, Inc. XERS Net debt / EBITDA

Net debt / EBITDA at other companies

Eli LillyLLY

1.1×-1.1×

Corcept TherapeuticsCORT

-2.5×-5.5×

Eton Pharmaceuticals, Inc.ETON

7.6×—

Zevra Therapeutics, Inc.ZVRA

-35.8×—

ANI PharmaceuticalsANIP

-0×-2.5×

Catalyst PharmaceuticalCPRX

-2.5×+0.4×

Other financials

Income statement

See full

Revenue$83.1M+38.3%

Gross profit$72.6M+41.2%

Operating income$7.9M+356%

Net income$2.2M+124%

EPS (diluted)$0.01+117%

Balance sheet

See full

Cash & equivalents$111.8M+91.2%

Total debt$258.6M-3.8%

Total equity$13.0M+137%

Total assets$392.0M+24.3%

Cash flow

See full

Operating cash flow$9.9M+198%

CapEx$131.0K—

Free cash flow-$29.1M—

Valuation

See full

Market cap$1.28B+76.9%

Enterprise value$1.42B+52.7%

P/E106.4×—

P/S4.1×+0.8×

Profitability

See full

Gross margin85.9%+3.7pp

Operating margin11.4%+7.7pp

Net margin3.8%+2.1pp

Returns & leverage

See full

Return on equity-209.8%—

Debt / equity19.9×—

Current ratio2.1×+0.4×

Where this comes from

Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.

net debt/ebitda=3.9×

Based on the most recent quarter.

The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xeris Biopharma Holdings, Inc.'s net debt / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Xeris Biopharma Holdings, Inc.'s net debt / EBITDA?: Xeris Biopharma Holdings, Inc. (XERS) reported net debt / EBITDA of 3.9× in Q1 2026.
What does net debt / EBITDA mean?: Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.